Circulating Platelet Products in Unstable Angina Pectoris

In 19 patients with unstable angina pectoris at rest, plasma levels of the platelet-derived proteins β-thromboglobulin and platelet factor 4 were significantly elevated in blood samples obtained during or within 4 hours after episodes of angina, but were usually normal during quiescent intervals. Plasma levels of the arachidonic acid metabolite thromboxane B2 were less clearly related to angina, and there was no association of angina with levels of the coagulation product fibrinopeptide A. This demonstration of an association of platelet activation and secretion with unstable angina pectoris by radioimmunoassay of circulating platelet constituents offers a new approach to assessment of therapy in ischemic heart disease and suggests that agents that alter platelet function should be evaluated in patients with unstable angina.

[1]  K. Gjesdal.  Platelet function and plasma free fatty acids during acute myocardial infarction and severe angina pectoris. , 2009, Scandinavian journal of haematology.

[2]  L. Green,et al.  Platelet activation during exercise-induced myocardial ischemia. , 1980, New England Journal of Medicine.

[3]  M. Inoue,et al.  Increased levels of thromboxane B2 in peripheral and coronary circulation in patients with coronary artery stenosis (effort angina) , 1979 .

[4]  J. Mehta,et al.  Platelet function studies in coronary artery disease. V. Evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction. , 1979, The American journal of cardiology.

[5]  P. Walinsky,et al.  Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina. , 1979, Prostaglandins and medicine.

[6]  H. Yasue,et al.  Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. , 1979, British journal of clinical practice. Supplement.

[7]  S. Chierchia,et al.  Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.

[8]  F. J. Morgan,et al.  Plasma Levels of Platelet Factor 4 Measured by Radioimmunoassay , 1978, British journal of haematology.

[9]  J. Mehta,et al.  Platelet Aggregation in Aortic and Coronary Venous Blood in Patients With and Without Coronary Disease , 1978, Circulation.

[10]  R. Baier,et al.  Thrombogenicity of Angiographic Catheters , 1978, Circulation research.

[11]  J. Maclouf,et al.  Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry. , 1978, Prostaglandins.

[12]  P. Steele,et al.  Platelet-suppressant therapy in patients with coronary artery disease. , 1978, JAMA.

[13]  J. Hirsh,et al.  Plasma fibrinopeptide A levels in symptomatic venous thromboembolism. , 1978, Blood.

[14]  M. Drillings,et al.  Radioimmunoassay of Platelet Factor 4 and β‐Thromboglobulin: Development and Application to Studies of Platelet Release in Relation to Fibrinopeptide A Generation , 1978, British journal of haematology.

[15]  M. Lesch,et al.  Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. , 1978, The Journal of laboratory and clinical medicine.

[16]  S. Niewiarowski.  Proteins Secreted by the Platelet , 1977, Thrombosis and Haemostasis.

[17]  J. Willerson.  Peripheral Venous Platelet Aggregates in Patients With Unstable Angina Pectoris and Acute Myocardial Infarction , 1977, Angiology.

[18]  P. B. Oliva,et al.  Arteriographic Evidence of Coronary Arterial Spasm in Acute Myocardial Infarction , 1977, Circulation.

[19]  K. Gjesdal,et al.  Half-Life of Platelet Factor 4 (PF-4) in Plasma and Platelets from Macaca Mulatta , 1977, Thrombosis and Haemostasis.

[20]  P. Needleman,et al.  Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. , 1977, Science.

[21]  J. Folts,et al.  Platelet Aggregation in Partially Obstructed Vessels and its Elimination with Aspirin , 1976, Circulation.

[22]  H. L. Nossel.  Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis. , 1976, The New England journal of medicine.

[23]  E. Haber,et al.  Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus. , 1976, The Journal of clinical investigation.

[24]  W. Frishman,et al.  Aspirin therapy in angina pectoris: effects on platelet aggregation, exercise tolerance, and electrocardiographic manifestations of ischemia. , 1976, American heart journal.

[25]  F. ten Hoor,et al.  Prostaglandins and the heart. , 1975, Journal of molecular and cellular cardiology.

[26]  D. Pepper,et al.  The release of a human platelet specific protein measured by a radioimmunoassay. , 1975, Thrombosis research.

[27]  A. Chandler.  Mechanisms and frequency of thrombosis in the coronary circulation. , 1974, Thrombosis research.

[28]  M. Stemerman,et al.  Thrombosis, atherosclerosis, and endothelium. , 1974, American heart journal.

[29]  S. Shapiro,et al.  An Analysis of Variance Test for Normality (Complete Samples) , 1965 .

[30]  M. Prinzmetal,et al.  Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.

[31]  B. Samuelsson,et al.  Thromboxane A2 and prostaglandin H2 form covalently linked derivatives with human serum albumin. , 1980, Advances in prostaglandin and thromboxane research.

[32]  S Moncada,et al.  The role of prostacyclin in vascular tissue. , 1979, Federation proceedings.

[33]  E. Salzman,et al.  Thromboxane B2 and fibrinopeptide A levels in platelet consumption and thrombosis. , 1978, Surgical forum.

[34]  K. Kaplan.  Proteins secreted by platelets: significance in detecting thrombosis. , 1978, Advances in experimental medicine and biology.

[35]  J. Ritchie,et al.  Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. , 1977, The American journal of cardiology.

[36]  J. Ritchie,et al.  Platelet and fibrinogen survival in coronary atherosclerosis , 1977 .

[37]  M. Dugdale,et al.  Platelet abnormalities in ischemic heart disease. , 1973, The American journal of cardiology.